Meningococcal Immunisation

Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

NCT05794230

Conditions

Healthy Volunteers, Meningococcal Immunisation

Locations

• Investigational Site Number : 3560006 — Chennai, India
• Investigational Site Number : 3560007 — Hyderabad, India
• Investigational Site Number : 3560016 — Kanpur, India
• Investigational Site Number : 3560009 — Kolkata, India

View all 15 locations View more locations Show fewer locations Loading locations...

View Trial Details

Completed

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

NCT06128733

Conditions

Healthy Volunteers, Meningococcal Immunisation

Locations

• Accel Research Site - Birmingham Clinical Research Unit- Site Number : 8400080 — Birmingham, Alabama, United States
• Lakeview Clinical Research Site Number : 8400029 — Guntersville, Alabama, United States
• Alliance for Multispecialty Research- Phoenix- Site Number : 8400056 — Tempe, Arizona, United States
• Harrisburg Family Medical Center Site Number : 8400070 — Harrisburg, Arkansas, United States

View all 47 locations View more locations Show fewer locations Loading locations...

View Trial Details

Completed

Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers

NCT06284915

Conditions

Healthy Volunteers, Meningococcal Immunisation

Locations

• Investigational Site Number : 2030002 — České Budějovice, Czechia
• Investigational Site Number: 2030001 — České Budějovice, Czechia
• Investigational Site Number: 2030005 — Prague, Czechia
• Investigational Site Number: 2080007 — Aalborg, Denmark

View all 45 locations View more locations Show fewer locations Loading locations...

View Trial Details

Completed

Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy

NCT05929651

Conditions

Healthy Volunteers, Meningococcal Immunisation

Locations

• Investigational Site Number : 0320002 — Buenos Aires, Buenos Aires F.D., Argentina
• Investigational Site Number : 0320001 — Ciudad Autonoma Buenos Aires, Argentina

View Trial Details

Completed

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents

NCT04490018

Conditions

Healthy Volunteers, Meningococcal Immunisation

Locations

• Investigational Site Number :3480003 — Budapest, Hungary
• Investigational Site Number :3480001 — Győr, Hungary
• Investigational Site Number :3480002 — Miskolc, Hungary
• Investigational Site Number :3480004 — Szigetvár, Hungary

View all 23 locations View more locations Show fewer locations Loading locations...

View Trial Details

Active, Not Recruiting

Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers

NCT04936685

Conditions

Healthy Volunteers, Meningococcal Immunisation

Locations

• Investigational Site Number : 2460009 — Espoo, Finland
• Investigational Site Number : 2460001 — Helsinki, Finland
• Investigational Site Number : 2460006 — Helsinki, Finland
• Investigational Site Number : 2460002 — Jarvenpaa, Finland

View all 26 locations View more locations Show fewer locations Loading locations...

View Trial Details